Cutting Edge Laser Technologies, ASA extend MLS distribution deal through 2033 with strategic investment

Cutting Edge Laser Technologies accepted a strategic investment from longtime manufacturing partner ASA and extended its exclusive North American distribution agreement through 2033. The deal deepens a nearly two-decade partnership and is aimed at expanding MLS® Laser Therapy across more medical, veterinary and aesthetics practices.

Why it matters: - The deal gives Cutting Edge Laser Technologies more capital to expand beyond its core market. - The extended agreement locks in exclusive North American distribution of MLS® Laser Therapy through 2033. - The companies said the partnership supports wider access to laser therapy in medical, veterinary and aesthetics practices.

What happened: - Cutting Edge Laser Technologies accepted a strategic investment from ASA, its longtime manufacturing partner and the developer of Multiwave Locked System® technology. - The companies extended their exclusive distribution agreement through 2033. - The announcement was made Aug. 12, 2026, in Rochester, New York.

The details: - The investment is meant to support Cutting Edge's accelerated growth strategy. - Planned uses include expansion into new clinical specialties, more investment in sales and service infrastructure, and further development of education and clinical support programs. - Cutting Edge and ASA have worked together for almost two decades. - The partnership has helped establish MLS® Laser Therapy in more than 6,000 practices across North America. - Cutting Edge says it serves more than 10,000 medical professionals across its medical, veterinary and aesthetics divisions. - Cutting Edge is celebrating its 25th anniversary in 2026. - ASA General Manager Damiano Guidolin said the companies have advanced the science of laser therapy together and that the 2033 extension gives both sides room to invest, innovate and grow. - Cutting Edge President and COO Mark Mollenkopf said the investment and extension allow the company to plan farther ahead than at any point in its history.

Between the lines: - The investment signals that ASA sees more value in backing distribution growth directly, not just supplying technology. - The long extension reduces near-term partnership uncertainty and may help both companies commit to longer sales, training and support plans. - The focus on education and clinical support suggests the companies are treating adoption as a service and training challenge, not just a product sale.

What's next: - Cutting Edge plans to use the new backing to enter additional clinical specialties and strengthen its customer support network. - The companies will continue promoting MLS® Laser Therapy across North American medical and veterinary markets under the extended agreement. - Cutting Edge directs readers to more information and ASA to the company's site.